RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway.

Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway.

Add to Collection
2016 May 15 Others Fist_Author_Year_PM

Full Author : ['Akhtar, Md Sayeed', 'Pillai, Krishna Kolappa', 'Hassan, Md Quamrul', 'Dhyani, Neha', 'Ismail, Md Vasim', 'Najmi, Abul Kalam']
Journal Title : Life sciences
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

AIMS: Diabetic cardiomyopathy (DCM) is one of the most common causes of mortality. Its pathophysiology is not fully understood and involve number of factors including, cardiovascular and metabolic disorders. The present study was designed to study the pat.....

Keywords : ["streptozotocin induce diabetic cardiomyopathy via pathway", "levosimendan reduce myocardial damage", "improve cardiodynamic"]